Sep 18 2009
Bruker Corporation (NASDAQ: BRKR) today announced an underwritten public secondary offering of 12,000,000 shares of its common stock by two members of the Laukien family not involved in the Company’s business. The selling stockholders also intend to grant the underwriters a 30-day option to purchase up to an additional 1,800,000 shares of common stock to cover over-allotments, if any. Bruker will not receive any of the proceeds from the sale of the shares of common stock by the selling stockholders in this offering. Goldman, Sachs & Co., J.P. Morgan Securities Inc. and Deutsche Bank Securities Inc. are acting as joint book-running managers of the proposed offering.
A shelf registration statement relating to the shares was filed with the Securities and Exchange Commission and is effective. Information about the secondary offering is available in the preliminary prospectus supplement filed with the Securities and Exchange Commission on September 18, 2009. This press release does not constitute an offer to sell, or a solicitation of an offer to buy, these securities, nor will there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale is not permitted.